|
Contents
|
|
|
|
Corneal
Angiogenesis
|
|
|
|
Joussen
AM, Kruse FE, Volcker HE, Kirchhof B
Topical
application of methotrexate for inhibition of corneal angiogenesis
Graefes
Arch Clin Exp Ophthalmol 1999 Nov;237(11):920-7
|
|
|
Embryonal
Tumors
|
|
|
|
S.
J. Kellie, J. Chaku, L. Lockwood, P. O'Regan, K. D. Waters, C. K. F. Wong
Cranial
radiation therapy following four courses of high-dose methotrexate: Late
follow-up of MRI features of leukoencephalopathy
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003.
Abstract No. 439
|
|
|
Malignant
Lymphoma
|
|
|
|
|
Abdelsalam
M, Elthusseiny G, Akhtar S, Khafaga Y, Alt Shabana M, Alhusaini H, El Weshi
A, Rahal M, Maghfoor I.
Improved survival with combined chemo-radiotherapy in primary central
nervous system lymphoma.
Hematol Oncol Stem Cell Ther. 2010 Oct 10;3(3):128-34.
.JPG)
Abstract | .png)
Reprint |
.gif)
Related articles
|
|
Jacob
Baram, Yonathan Goldhammer, Zvi Ram, Thomas Tichler, Dvora Nass, Raffael
Catane, Raffael Pfeffer, Ilan Blatt
Any
role for brain irradiation in the treatment of primary central nervous system
lymphoma (PCNSL)?
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
|
|
T. Batchelor, S. Grossman, K.
Carson, J. Fisher
Updated results from NABTT CNS consortium studies
in primary CNS lymphoma
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1519
|
|
P.
Colombat, T. Lamy, A. Lemevel, V. Delwail, M. Gardembas, A. Brion, C.
Berthou, J.-O. Bay, R. Delepine, C. Linassier
Phase II trial of high-dose chemotherapy with
autologous stem cell transplantation in first-line therapy of primary
central nervous system (CNS) lymphoma
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
400
|
|
Andrés J Ferreri, Massimo Bernardi,
Stefania Dell'Oro, Alba A Brandes, Michele Reni, Fabio Ciceri, Lara M Pasetto,
Michele Spina, Caterina Stelitano, Monica Balzarotti, Fiorella Ilariucci,
Maurilio Ponzoni, Alberto Franzin, Romano Danesi, Eugenio Villa
CLIMT-2:
an ongoing phase-II multicentre trial of MATILde chemotherapy regimen (methotrexate-cytarabine-thiotepa-idarubicin)
in HIV-negative primary CNS lymphomas (PCNSL)
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
|
|
K. Jahnke, A.
Korfel, P. Martus, M. Weller, U. Herrlinger, L. Fischer, E. Thiel
Comparison of high-dose methotrexate (HDMTX)
toxicity in elderly and younger patients (pts) with primary central nervous
system lymphoma (PCNSL)
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8041
|
|
|
Kiewe P, Fischer L, Martus P, Thiel E, Korfel A
Primary central nervous system lymphoma: monocenter, long-term,
intent-to-treat analysis
Cancer. 2008 Apr 15;112(8):1812-20
Abstract
|
|
A.
Korfel, M.R. Nowrousian Sr., D. K Hossfeld Sr., W. Weber Sr., J. Brücher,
W. E Berdel Sr., J. Birkmann Sr., Ch. Peschel, R. Pasold, B. Gleissner, L.
Fischer, E. Thiel
Chemotherapy
+/- whole-brain irradiation (WBI) for primary CNS lymphoma (PCNSL) - first
experience with a randomized trial
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. 298
|
|
Benjamin
E Lawler, Rebecca Betensky, Fred Hochberg, Tracy Batchelor
Primary
central nervous system lymphoma: the Massachusetts General Hospital experience,
1987-2001
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. 299
|
|
|
Omuro AM, Taillandier L, Chinot O, Carnin C,
Barrie M, Hoang-Xuan K.
Temozolomide and methotrexate for primary central nervous system lymphoma
in the elderly
J Neurooncol.
2007 Nov;85(2):207-11.
Epub 2007 Sep 21
Abstract
|
|
Hendrik Pels, Ingo G.H. Schmidt-Wolf,
Axel Glasmacher, Holger Schulz, Andreas Engert,
Volker Diehl, Anton Zellner, Gabriele Schackert,
Heinz Reichmann, Frank Kroschinsky, Marlies
Vogt-Schaden, Gerlinde Egerer, Udo Bode, Carlo
Schaller, Martina Deckert, Rolf Fimmers, Christoph
Helmstaedter, Aslihan Atasoy, Thomas Klockgether,
Uwe Schlegel
Primary Central Nervous System Lymphoma: Results of a
Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With
Deferred Radiotherapy
Journal of Clinical Oncology, Vol 21, Issue 24 (December), 2003:
4489-4495
|
|
Philip M.P. Poortmans, Hanneke C. Kluin-Nelemans, Hanny
Haaxma-Reiche, Mars Van’t Veer, Mads Hansen, Pierre
Soubeyran, Martin Taphoorn, José Thomas, Martin
Van den Bent, Martin Fickers, Gustaaf Van Imhoff,
Cynthia Rozewicz, Ivana Teodorovic, Martine van
Glabbeke
High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy
in Non–AIDS-Related Primary Central Nervous System Lymphoma: European
Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial
20962
Journal of Clinical Oncology, Vol 21, Issue 24 (December), 2003:
4483-4488
|
|
|
Silvani
A, Salmaggi A, Eoli M, Lamperti E, Broggi G, Marras CE, Fariselli L,
Milanesi I, Fiumani A, Gaviani P, Erbetta A, Giovagnoli AR, Pollo B, Botturi
A, Boiardi A.
Methotrexate based chemotherapy and deferred radiotherapy for primary
central nervous system lymphoma (PCNSL): single institution experience.
J Neurooncol.
2007 May;82(3):273-9. Epub 2006 Nov 17.
PMID: 17111190 [PubMed - indexed for MEDLINE]
|
|
|
Medulloblastoma
|
|
|
|
Radiotherapy,
Lomustine, Methotrexate, Vincristine
|
Massimino M, Cefalo G, Riva D, Biassoni V, Spreafico F, Pecori E, Poggi G,
Collini P, Pollo B, Valentini L, Potepan P, Seregni E, Casanova M, Ferrari
A, Luksch R, Polastri D, Terenziani M, Pallotti F, Clerici CA, Schiavello E,
Simonetti F, Meazza C, Catania S, Podda M, Gandola L.
Long-term
results of combined preradiation chemotherapy and age-tailored radiotherapy
doses for childhood medulloblastoma.
J Neurooncol.
2012 Feb 16. [Epub ahead of print]
Abstract |
Related articles
|
|
F.
Spreafico, M. Massimino, L. Gandola, S. Siena, G. Cefalo, E. Mazza, P.
Versari, G. Landonio, P. Pedrazzoli, F. Fossati-Bellani
Survival
results in adults treated for medulloblastoma
39th
ASCO Annual Meeting, Chicago IL, May 31-June 3, 2003, Abstract No. 479
|
|
|
Yoshimura J, Nishiyama K, Mori H, Takahashi H,
Fujii Y
Intrathecal chemotherapy for refractory disseminated medulloblastoma
Childs
Nerv Syst. 2007 Dec 5; [Epub ahead of print]
.png)
Full Text |
Reprint
|
|
|
Metastatic
Tumors
|
|
|
|
Colleoni M, Rocca A, Sandri MT,
Zorzino L, Masci G, Nole F, Peruzzotti G, Robertson C, Orlando L, Cinieri S, de
BF, Viale G, Goldhirsch A
Low-dose
oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor
activity and correlation with vascular endothelial growth factor levels
Ann
Oncol 2002 Jan;13(1):73-80
|
|
Andrew B. Lassman, Lauren E. Abrey,
Gaurav G. Shah, Katherine S. Panageas, Martin Begemann,
Mark G. Malkin and Jeffrey J. Raizer
Systemic high-dose intravenous methotrexate for central nervous system
metastases
J Neurooncol. 2006
Jul;78(3):255-60. Epub 2005 Dec 13
Abstract
|
|
Andrew
B Lassman, Lauren
E Abrey, Martin Begemann, Katherine J Picconi, Kelly Vuksanaj, Mark G Malkin,
Jeffrey J Raizer
Systemic
high dose methotrexate (HD MTX) for central nervous system (CNS) metastases
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No. 2083
|
|
Laura Orlando, Anna Cardillo, Raffaella Ghisini,
Andrea Rocca, Alessandra Balduzzi, Rosalba Torrisi, Giulia Peruzzotti, Aron
Goldhirsch, Elisabetta Pietri, and Marco Colleoni
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate
in patients with HER-2 positive metastatic breast cancer
BMC Cancer. 2006 Sep
15;6:225
Abstract
|
Full
Text |
Reprint
|
|
M.E.M. Rentinck, H.M. Schrijver, E. Kneppers,
J.C.M. Zijlmans, C.J. van Groeningen
Carcinomatous
Meningitis in Cancer of the Uterine Cervix
J
Neurooncol, 70(1):87-90,
Oct. 2004.
(Abstract+)
|
|
|
Primary
CNS Lymphoma
|
|
|
|
|
Cobert J, Hochberg E, Woldenberg N, Hochberg F
Monotherapy
with methotrexate for primary central nervous lymphoma has single agent
activity in the absence of radiotherapy: a single institution cohort.
J
Neurooncol. 2010 Jul;98(3):385-93. Epub 2009 Dec 18
Abstract |
Full Text |
Reprint |
Related articles
|
|
Igor T. Gavrilovic, Adília
Hormigo, Joachim Yahalom, Lisa M. DeAngelis,
Lauren E. Abrey
Long-Term Follow-Up of High-Dose
Methotrexate-Based
Therapy With and Without Whole Brain Irradiation for Newly Diagnosed Primary
CNS Lymphoma
J
Clin Oncol. 2006 Oct 1;24(28):4570-4. DOI: 10.1200/JCO.2006.06.6910
|
|
Herrlinger U, Kuker W, Uhl M, Blaicher
HP, Karnath HO, Kanz L, Bamberg M, Weller M; Neuro-Oncology Working Group of
the German Society
NOA-03 trial of high-dose
methotrexate in primary central nervous system lymphoma: final report
Ann
Neurol. 2005 Jun;57(6):843-7.
|
|
|
Illerhaus G, Marks R, Ihorst G, Guttenberger R,
Ostertag
C, Derigs G, Frickhofen N, Feuerhake F, Volk B, Finke J.
High-dose chemotherapy with autologous
stem-cell transplantation and hyperfractionated radiotherapy as first-line
treatment of primary CNS lymphoma.
J
Clin Oncol. 2006 Aug
20;24(24):3865-70. Epub 2006 Jul 24.
Abstract
|
|
|
Shah GD, Yahalom J, Correa DD, Lai RK, Raizer JJ,
Schiff D, LaRocca R, Grant B, DeAngelis LM, Abrey LE.
Combined immunochemotherapy with reduced whole-brain radiotherapy for
newly diagnosed primary CNS lymphoma.
J
Clin Oncol. 2007 Oct 20;25(30):4730-5.
Abstract
|
|
